These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 38479588)

  • 1. Escherichia coli as a versatile cell factory: Advances and challenges in recombinant protein production.
    İncir İ; Kaplan Ö
    Protein Expr Purif; 2024 Jul; 219():106463. PubMed ID: 38479588
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Strategies for efficient production of heterologous proteins in Escherichia coli.
    Jana S; Deb JK
    Appl Microbiol Biotechnol; 2005 May; 67(3):289-98. PubMed ID: 15635462
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Production of recombinant serpins in Escherichia coli.
    Bird PI; Pak SC; Worrall DM; Bottomley SP
    Methods; 2004 Feb; 32(2):169-76. PubMed ID: 14698629
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Strategies to optimize protein expression in E. coli.
    Francis DM; Page R
    Curr Protoc Protein Sci; 2010 Aug; Chapter 5(1):5.24.1-5.24.29. PubMed ID: 20814932
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Resolving bottlenecks for recombinant protein expression in E. coli.
    Peleg Y; Unger T
    Methods Mol Biol; 2012; 800():173-86. PubMed ID: 21964789
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Learning to predict expression efficacy of vectors in recombinant protein production.
    Chan WC; Liang PH; Shih YP; Yang UC; Lin WC; Hsu CN
    BMC Bioinformatics; 2010 Jan; 11 Suppl 1(Suppl 1):S21. PubMed ID: 20122193
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Strategies for production of active eukaryotic proteins in bacterial expression system.
    Khow O; Suntrarachun S
    Asian Pac J Trop Biomed; 2012 Feb; 2(2):159-62. PubMed ID: 23569889
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Optimization of culture parameters and novel strategies to improve protein solubility.
    Arya R; Sabir JS; Bora RS; Saini KS
    Methods Mol Biol; 2015; 1258():45-63. PubMed ID: 25447858
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of three industrial Escherichia coli strains in fed-batch cultivations during high-level SOD protein production.
    Marisch K; Bayer K; Cserjan-Puschmann M; Luchner M; Striedner G
    Microb Cell Fact; 2013 Jun; 12():58. PubMed ID: 23758670
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Strategies for the production of recombinant protein in Escherichia coli.
    Gopal GJ; Kumar A
    Protein J; 2013 Aug; 32(6):419-25. PubMed ID: 23897421
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Influence of the reductase deficient Escherichia coli on the solubility of recombinant proteins produced in it].
    Xiong S; Zhang MY; Qian CW; Ran YC; Wang YF; Ren XR; Su KY; Yu ZY
    Sheng Wu Gong Cheng Xue Bao; 2003 Nov; 19(6):686-91. PubMed ID: 15971580
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A strategy for the expression of recombinant proteins traditionally hard to purify.
    Frank EG; McDonald JP; Karata K; Huston D; Woodgate R
    Anal Biochem; 2012 Oct; 429(2):132-9. PubMed ID: 22828411
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chaperone-fusion expression plasmid vectors for improved solubility of recombinant proteins in Escherichia coli.
    Kyratsous CA; Silverstein SJ; DeLong CR; Panagiotidis CA
    Gene; 2009 Jul; 440(1-2):9-15. PubMed ID: 19328840
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Overview of the purification of recombinant proteins produced in Escherichia coli.
    Wingfield PT
    Curr Protoc Protein Sci; 2003 Feb; Chapter 6():6.1.1-6.1.37. PubMed ID: 18429246
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predictive approaches to guide the expression of recombinant vaccine targets in Escherichia coli: a case study presentation utilising Absynth Biologics Ltd. proprietary Clostridium difficile vaccine antigens.
    Hussain H; McKenzie EA; Robinson AM; Gingles NA; Marston F; Warwicker J; Dickson AJ
    Appl Microbiol Biotechnol; 2021 Jul; 105(13):5657-5674. PubMed ID: 34180005
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Revisiting Escherichia coli as microbial factory for enhanced production of human serum albumin.
    Sharma A; Chaudhuri TK
    Microb Cell Fact; 2017 Oct; 16(1):173. PubMed ID: 28982367
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Optimizing scaleup yield for protein production: Computationally Optimized DNA Assembly (CODA) and Translation Engineering.
    Hatfield GW; Roth DA
    Biotechnol Annu Rev; 2007; 13():27-42. PubMed ID: 17875472
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Translational regulation of periplasmic folding assistants and proteases as a valuable strategy to improve production of translocated recombinant proteins in Escherichia coli.
    Gawin A; Ertesvåg H; Hansen SAH; Malmo J; Brautaset T
    BMC Biotechnol; 2020 May; 20(1):24. PubMed ID: 32393331
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An insight into fusion technology aiding efficient recombinant protein production for functional proteomics.
    Yadav DK; Yadav N; Yadav S; Haque S; Tuteja N
    Arch Biochem Biophys; 2016 Dec; 612():57-77. PubMed ID: 27771300
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increasing recombinant protein production in Escherichia coli through metabolic and genetic engineering.
    Waegeman H; Soetaert W
    J Ind Microbiol Biotechnol; 2011 Dec; 38(12):1891-910. PubMed ID: 21901404
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.